NATURE’S SUNSHINE PRODUCTS, INC. Total Contract Liability
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Total Contract Liability of $0 as of 2021-12-31, per its 10-K filed 2022-03-08.
Discontinued › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2022-03-08
- 2021-12-31: Contract with Customer, Liability $0.00.
- 2021-03-31: Contract with Customer, Liability $984.00K.
- 2020-12-31: Contract with Customer, Liability $983.00K.
- 2020-09-30: Contract with Customer, Liability $801.00K.
| Period end | Contract with Customer, Liability |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-08 |
| 2021-03-31 | $984.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $983.00K 10-K · filed 2022-03-08 |
| 2020-09-30 | $801.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $904.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $927.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $955.00K 10-K · filed 2022-03-08 |
| 2019-09-30 | $1.06M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.11M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.12M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.08M 10-K · filed 2021-03-10 |
| 2018-09-30 | $1.32M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.43M 10-Q · filed 2018-08-08 |
| 2017-12-31 | $1.13M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |